Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma

Biochemical and Biophysical Research Communications

Volumn 358, Issue 1, 2007, Pages 124-129

  Zhang, Youlei ^a   Li, Li ^b   Wang, Yi ^a   Zhang, Jun ^c   Wei, Gongtian ^a   Sun, Yanfu ^a   Shen, Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Antisense oligodeoxynucleotide; Heparanase; Human hepatocellular carcinoma; Invasion; Metastasis; Small interfering RNA

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; HEPARANASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; GLUCURONIDASE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; RNA, SMALL INTERFERING;

EID: 34248187724     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.04.068     Document Type: Article

References (28)

1. Schafer D.F., and Sorrell M.F. Hepatocellular carcinoma. Lancet 353 (1999) 1253-1257
2. Sasisekharan R., Shriver Z., Venkataraman G., and Narayanasami U. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2 (2002) 521-528
3. Parish C.R., Freeman C., and Hulett M.D. Heparanase: a key enzyme involved in cell invasion. Biochim. Biophys. Acta 1471 (2001) M99-M108
4. Vlodavsky I., and Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest. 108 (2001) 341-347
5. Vlodavsky I., Goldshmidt O., Zcharia E., Atzmon R., Rangini-Guatta Z., Elkin M., Peretz T., and Friedmann Y. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin. Cancer Biol. 12 (2002) 121-129
6. Vlodavsky I., Friedmann Y., Elkin M., Aingorn H., Atzmon R., Ishai-Michaeli R., Bitan M., Pappo O., Peretz T., Michal I., Spector L., and Pecker I. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat. Med. 5 (1999) 793-802
7. Hulett M.D., Freeman C., Hamdorf B.J., Baker R.T., Harris M.J., and Parish C.R. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat. Med. 5 (1999) 803-809
8. McKenzie E., Tyson K., Stamps A., Smith P., Turner P., Barry R., Hircock M., Patel S., Barry E., Stubberfield C., Terrett J., and Page M. Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem. Biophys. Res. Commun. 276 (2000) 1170-1177
9. Friedmann Y., Vlodavsky I., Aingorn H., Aviv A., Peretz T., Pecker I., and Pappo O. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am. J. Pathol. 157 (2000) 1167-1175
10. Zcharia E., Metzger S., Chajek-Shaul T., Friedmann Y., Pappo O., Aviv A., Elkin M., Pecker I., Peretz T., and Vlodavsky I. Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis. J. Mammary Gland Biol. Neoplasia 6 (2001) 311-322
11. Koliopanos A., Friess H., Kleeff J., Shi X., Liao Q., Pecker I., Vlodavsky I., Zimmermann A., and Buchler M.W. Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res. 61 (2001) 4655-4659
12. Cohen I., Pappo O., Elkin M., San T., Bar-Shavit R., Hazan R., Peretz T., Vlodavsky I., and Abramovitch R. Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int. J. Cancer 118 (2006) 1609-1617
13. EL-Assal O.N., Yamanoi A., Ono T., Kohno H., and Nagasue N. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma. Clin. Cancer Res. 7 (2001) 1299-1305
14. Bar-Sela G., Kaplan-Cohen V., Ilan N., Vlodavsky I., and Ben-Izhak O. Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival. Histopathology 49 (2006) 188-193
15. Ikeguchi M., Hirooka Y., and Kaibara N. Heparanase gene expression and its correlation with spontaneous apoptosis in hepatocytes of cirrhotic liver and carcinoma. Eur. J. Cancer 39 (2003) 86-90
16. Parish C.R., Coombe D.R., Jakobsen K.B., Bennett F.A., and Underwood P.A. Evidence that sulphated polysaccharides inhibit tumor metastasis by blocking tumor-cell-derived heparanase. Int. J. Cancer 40 (1987) 511-558
17. Vlodavsky I., Mohsen M., Lider O., Svahn C.M., Ekre H.P., Vigoda M., Ishai-Michaeli R., and Peretz T. Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis 14 (1994) 290-302
18. Parish C.R., Freeman C., Brown K.J., Francis D.J., and Cowden W.B. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res. 59 (1999) 3433-3441
19. Miao H.Q., Elkin M., Aingorn E., Ishai-Michaeli R., Stein C.A., and Vlodavsky I. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int. J. Cancer 83 (1999) 424-431
20. Uno F., Fujiwara T., Takata Y., Ohtani S., Katsuda K., Takaoka M., Ohkawa T., Naomoto Y., Nakajima M., and Tanaka N. Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells. Cancer Res. 61 (2001) 7855-7860
21. Roy M., Reiland J., Murry B.P., Chouljenko V., Kousoulas K.G., and Marchetti D. Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion. Neoplasia 7 (2005) 253-262
22. Edovitsky E., Elkin M., Zcharia E., Peretz T., and Vlodavsky I. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J. Natl. Cancer Inst. 96 (2004) 1219-1230
23. Zhang Y., Fu Z., Zhang J., Wang Y., and Shen Q. Inhibition of invasiveness of human mammary carcinoma cell line MDA435 by heparanase antisense oligodeoxynucleotide. Natl. Med. J. China 83 (2003) 204-207
24. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
25. Chen T., Guo J., Yang M., Han C., Zhang M., Chen W., Liu Q., Wang J., and Cao X. Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood 103 (2004) 413-421
26. Crooke S.T. Molecular mechanisms of action of antisense drugs. Biochim. Biophys. Acta. 1489 (1999) 31-44
27. Tamm I., Dorken B., and Hartmann G. Antisense therapy in oncology: new hope for an old idea?. Lancet 358 (2001) 489-497
28. Pai S.I., Lin Y.Y., Macaes B., Meneshian A., Hung C.F., and Wu T.C. Prospects of RNA interference therapy for cancer. Gene Ther. 13 (2006) 464-477